Related Experiment Video
Updated: May 16, 2025

An In Ovo Model for Testing Insulin-mimetic Compounds
Published on: April 23, 2018
Antidiabetic activity of polyherbal formulations: a comprehensive review
Aditya Jain1, Tanvi Jangid1, Ram Niwas Jangir2
1Department of Zoology, University of Rajasthan, Jaipur, Rajasthan, 302004, India.
None:
Diabetes mellitus is a chronic condition marked by high blood glucose levels, resulting from either insufficient insulin production or poor insulin function. While conventional treatments have progressed, there is growing interest in alternative therapies, especially polyherbal formulations, due to their natural origin, cost-effectiveness, and fewer side effects. This review uniquely explores the antidiabetic potential of polyherbal formulations derived from various plants, focusing on their synergistic effects, where combinations of plant species work together to enhance therapeutic, outcomes. It discusses common plants used, types of extracts, plant parts, and dosing regimens in experimental studies. Both in vitro and in vivo models are examined to assess the effectiveness of these formulations in managing diabetes. The mechanisms behind their antidiabetic action-such as boosting insulin secretion, improving insulin sensitivity, regulating glucose metabolism, and reducing oxidative stress and inflammation-are highlighted. Overall, polyherbal formulations offer significant promise for integrating into diabetes management and reducing complications when used alongside conventional therapies. This review underscores the novelty of using polyherbal combinations to enhance diabetes treatment, offering a holistic and cost-effective approach to management. In conclusion, further research into these formulations could lead to more accessible and personalized therapeutic options for diabetes patients worldwide.
More Related Videos
13:09Rapid Model to Evaluate the Anti-Obesity Potential of a Combination of Syzygium aromaticum Clove and Cuminun cyminum Cumin on C57BL6/j Mice Fed High-Fat Diet
Published on: July 31, 2021
08:15Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
Published on: May 10, 2024
Related Concept Videos
Oral Hypoglycemic Agents: Biguanides and Glitazones
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
Acarbose and miglitol are...
Oral Hypoglycemic Agents: Glinides
Dipeptidyl Peptidase 4 Inhibitors
Oral Hypoglycemic Agents: Sulfonylureas
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...